Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors.
Reporting to the Chief Medical Officer, the Vice President or Sr.
Vice President, Head of Medical Affairs will lead the U.S.
Full posting locked
Company, description, requirements, and direct apply unlock with a subscription.